Completed NA INTERVENTIONAL 2-arm NCT02459678

ART Readiness in HIV-infected Pregnant Women

ART Readiness in HIV-infected Pregnant Women: From Formative Qualitative Research to Individual Randomized Trial

Sponsor: Centers for Disease Control and Prevention

Interventions Enhanced Adherence Package Standard of Care

Updated 7 times since 2017 Last updated: Sep 14, 2018 Started: May 31, 2015 Primary completion: May 9, 2018 Completion: May 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02459678, this NA trial focuses on Human Immunodeficiency Virus and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2018 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2018 — Oct 2018 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jul 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Jul 2017 [monthly]

Recruiting NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
Centre for Infectious Disease Research in Zambia
University of North Carolina, Chapel Hill

Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lusaka, Zambia